| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 02/18/2009 | EP2024003A1 REGULATION OF TRANSFORMING GROWTH FACTOR-BETA (TGF- ß) GENE EXPRESSION IN LIVING CELLS VIA THE APPLICATION OF SPECIFIC AND SELECTIVE ELECTRIC AND ELECTROMAGNETIC FIELDS |
| 02/18/2009 | EP1732903B1 Triazolone derivatives as mmp inhibitors for the treatment of asthma and copd |
| 02/18/2009 | EP1682167B1 Use of hyperpolymer haemoglobin for treating a pulmonary oedema |
| 02/18/2009 | EP1399431B1 Novel nitriles useful as reversible inhibitors of cysteine proteases |
| 02/18/2009 | EP1028945B9 Substituted pyridine compounds as anti-inflammatory agents |
| 02/18/2009 | CN101370829A Chimeric and humanised anti-human IL-13 antibodies |
| 02/18/2009 | CN101370793A Novel N-(fluoro-pyrazinyl)-phenylsulfonamid.es as moodulators of chemokine receptor CCR4 |
| 02/18/2009 | CN101370502A Use of naphthyridine derivatives as medicaments |
| 02/18/2009 | CN101366942A Prescription for treating children's chronic cough |
| 02/18/2009 | CN101366933A Lung cancer treating medicine |
| 02/18/2009 | CN101366920A Prick removing lozenge for laryngopharynx and preparation |
| 02/18/2009 | CN101366917A Traditional Chinese medicine composition for treating chronic pharyngitis |
| 02/18/2009 | CN101366915A Traditional Chinese medicine for treating bronchitis |
| 02/18/2009 | CN101366909A Traditional Chinese medicine for treating common cold |
| 02/18/2009 | CN101366905A Traditional Chinese medicine pill for treating cough and asthma, and preparation method |
| 02/18/2009 | CN101366877A Prescription for treating damp-heat old sputum of persons in middle and old age |
| 02/18/2009 | CN101366876A Traditional Chinese medicine preparation for treating throat irritation and preparation method thereof |
| 02/18/2009 | CN101366858A Preparation method of medicament for clearing heat, discharging fire, dispelling wind and relieving pain |
| 02/18/2009 | CN101366850A Rhinitis treating medicament and preparation method |
| 02/18/2009 | CN101366849A Quality control method for traditional Chinese medicine citrus aurantium |
| 02/18/2009 | CN101366844A New use of loquat flower and its extract |
| 02/18/2009 | CN101366790A Propolis oral liquid and uses thereof |
| 02/18/2009 | CN101366739A Cough relieving cigarette |
| 02/18/2009 | CN100462359C 5-sulfanyl-4H-1,2,4-triazole derivatives and their use as a medicament |
| 02/18/2009 | CN100462352C Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents |
| 02/18/2009 | CN100462088C Medicine for preventing child amygdalitis |
| 02/17/2009 | US7491825 e.g. N-[2-[4-(2-(S)-amino-6-dimethylamino-hexanoyl)-piperazin-1-yl]-1,1-dimethyl-2-oxo-ethyl]-2,4-dichloro-3-(2-methyl -quinolin-8-yloxy-methyl)-benzensulfonamide trifluoroacetate; antiinflammatory agent; asthma, chronic bronchitis, allergic rhinitis, obstructive pulmonary disease (COPD) |
| 02/17/2009 | US7491740 Isoxazoline compounds having MIF antagonist activity |
| 02/17/2009 | US7491734 psychotic and intellectual impairment disorders; Alzheimer's disease, cognitive or attention disorders, antidepressant, anxiolytic agent; ,smoking cessation, neuroprotection, schizophrenia, analgesia, Tourette's syndrome, and Parkinson's disease |
| 02/17/2009 | US7491730 Compositions useful as inhibitors of GSK-3 |
| 02/17/2009 | US7491722 Pyridazin-3(2H)-one derivatives |
| 02/17/2009 | US7491719 adrenergic blocking agents such as R-6-Hydroxy-8-{1-hydroxy-2-[2-(4-methoxyphenyl)-1,1-dimethylethylamino]ethyl}-4H-benzo[1,4]oxazin-3-one hydrochloride, used for the treatment of repiratoty system disorders |
| 02/17/2009 | US7491706 Containing a single-stranded oligonucleotide DNA molecule containing one or more CpG(s); SARS virus, hepatitis C virus, dengue virus and Japanese encephalitis, influenza virus |
| 02/17/2009 | US7491677 Composite sample on support; concentration gradients |
| 02/17/2009 | US7491550 Diagnostics and therapeutics for diseases associated with Neuromedin U2 receptor (NMU2) |
| 02/17/2009 | US7491392 An isolated IL-1 beta binding molecule comprising a heavy chain variable domain; treatment of an IL-1 mediated disease or disorder, e.g. osteoarthritis, osteroporosis and other inflammatory arthritis |
| 02/17/2009 | CA2445189C Carboline derivatives as pdev inhibitors |
| 02/17/2009 | CA2400217C Pteridine compounds for the treatment of psoriasis |
| 02/17/2009 | CA2383555C 3(5)-amino-pyrazole derivatives, process for their preparation and their use as antitumor agents |
| 02/17/2009 | CA2355283C Method for treatment of bacterial infections with once or twice-weekly administered rifalazil |
| 02/12/2009 | WO2009020534A2 Method of treating cxcr3 mediated diseases using heterocyclic substituted piperazines |
| 02/12/2009 | WO2009018909A2 Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors |
| 02/12/2009 | WO2009018908A1 Synthetic pulmonary surfactant peptides |
| 02/12/2009 | WO2008071605A3 Methods of treating inflammatory diseases |
| 02/12/2009 | US20090042954 Trans-2-(4-(5-(4-(2-methylpropyl)phenyl)-1,2,4-oxadiazol-3-yl)phenyl)-4-pyrrolidineacetic acid; have immunosuppressive, anti-inflammatory and hemostatic activities by modulating leukocyte trafficking, sequestering lymphocytes in secondary lymphoid tissues, and enhancing vascular integrity |
| 02/12/2009 | US20090042931 Tricyclic Angiotensin II Agonists |
| 02/12/2009 | US20090042891 6-(3-Fluorophenyl)-5-pyridin-4-ylpyrazin-2-amine, used in the treatment of asthma, chronic obstructive pulmonary disorder, fibrosis, emphysema, allergies, inflammation, reperfusion injury, ischemia, atherosclerosis, hypertension, retinopathy, diabetes, inflammatory bowel disease or autoimmune diseases |
| 02/12/2009 | US20090042885 2-(2-((2R)-2-heptylaminomethyl-5-oxopyrrolidin-1-yl)ethylthio)-1,3-thiazole-4-carboxylic acid; EP2 and/or EP4 receptor agonist; immune disease; antiallergens; alopecia; dysmenorrhea; erectile dysfuncction; antiarthritic agents; liver, respiratory, vascular, urogenital disorder |
| 02/12/2009 | US20090042879 Phthalazinone derivatives and pharmaceutical compositions comprising the same |
| 02/12/2009 | US20090042877 such as ethyl 6-oxo-7-phenyl-3-(pyridin-3-ylamino)-6,7-dihydrothieno [2,3-b]pyridine-2-carboxylate, potent and selective inhibitors of p38 MAP kinase and are of use in the prophylaxis and treatment of immune or inflammatory disorders |
| 02/12/2009 | US20090042873 Tricyclic n-heteroaryl-carboxamide derivatives containing a benzimidazole unit, method for preparing same and their therapeutic use |
| 02/12/2009 | US20090042854 Hexahydro-3H-Pyrrolizin-3-Ones Useful as Tachykinin Receptor Antagonists |
| 02/12/2009 | US20090042843 Inhalation Device Containing Plural Doses of a Pharmaceutical Composition |
| 02/12/2009 | US20090042815 Macrolide Synthesis Process and Solid-State Forms |
| 02/12/2009 | US20090042807 By reducing macrophage NO production through administration of one or more enzyme inhibitors, selected from tripeptides, tetrapeptides and pentapeptides; inhibition of neucrosis factor kappa Beta mediated inflammatory cytokine release |
| 02/12/2009 | US20090042796 Derivatives of the il-2 receptor gamma chain, their production and use |
| 02/12/2009 | US20090042199 Nucleotide sequences coding lymphocyte adhesion protein for use in treatment of autoimmunity, inflammation and infection |
| 02/12/2009 | US20090041742 Human dnase ii |
| 02/12/2009 | US20090041738 Method for treating a pulmonary disease state in mammals by up or down regulating indigenous in vivo levels of inflammatory agents in mammalian cells |
| 02/12/2009 | US20090041726 Tumor therapy with high affinity laminin receptor-target vectors and combinations with chemotherapeutic agents |
| 02/12/2009 | US20090041724 Protein Delivery System |
| 02/12/2009 | US20090041722 Indole indane amide compounds useful as cb2 agonists and method |
| 02/12/2009 | US20090041675 Organic compounds |
| 02/12/2009 | US20090041660 new monoclonal antibodies and binding fragments which recognize and immunoreact with cell surface antigens found on small cell lung cancer (SCLC) cells; antibodies have tumor specificity and are useful for therapy, diagnosis, monitoring, detecting and imaging of SCLC disease |
| 02/12/2009 | DE10064219B9 Neue Fentanyl und/oder dessen Derivate enthaltende pharmazeutische Zusammensetzung zur nasalen Anwendung New fentanyl and / or its derivatives containing pharmaceutical composition for nasal administration |
| 02/12/2009 | CA2695805A1 Synthetic pulmonary surfactant peptides |
| 02/12/2009 | CA2695580A1 Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors |
| 02/12/2009 | CA2695365A1 Method of treating cxcr3 mediated diseases using heterocyclic substituted piperazines |
| 02/12/2009 | CA2694140A1 Method for treating a pulmonary disease state in mammals by up or down regulating indigenous in vivo levels of inflammatory agents in mammalian cells |
| 02/11/2009 | EP2022798A1 Synthetic pulmonary surfactant peptides |
| 02/11/2009 | EP2022796A1 Amorphous ciclesonide |
| 02/11/2009 | EP2022783A1 "Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors" |
| 02/11/2009 | EP2021797A2 Compositions of n-ý2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl¨-1,4-dihydro-4-oxoquinoline-3-carboxamide |
| 02/11/2009 | EP2021335A1 Heterocyclic compounds as inhibitors of c-fms kinase |
| 02/11/2009 | EP2021329A1 Inhibitors of c-fms kinase |
| 02/11/2009 | EP2021013A2 Tracheal cytotoxin (tct) and related compounds for suppressing immune responses |
| 02/11/2009 | EP2021004A2 Substituted azaspiro derivatives |
| 02/11/2009 | EP1478236B1 Targeted retrograde gene delivery to motor neurons |
| 02/11/2009 | EP1370561B1 Tetrahydro-pyrazino[1,2-a]indoles for the treatment of central nervous disorders |
| 02/11/2009 | EP1309334B1 Combination therapy using reovirus and anti-antireovirus antibodies for the treatment of ras-mediated proliferative disorders |
| 02/11/2009 | CN201192473Y Medicine paste for treating tracheitis |
| 02/11/2009 | CN101365697A Tetomilast polymorphs |
| 02/11/2009 | CN101365474A Interferon lambda therapy for treatment of respiratory diseases |
| 02/11/2009 | CN101365450A Stable pharmaceutical formulations of montelukast sodium |
| 02/11/2009 | CN101365437A Compositions of cis-9, trans-11 conjugated linoleic acid and vaccenic acid and uses thereof |
| 02/11/2009 | CN101363819A Quality control method for yuye qinghuo capsule |
| 02/11/2009 | CN101362744A Sialic acid analogue and application thereof in anti-influenza virus medicament |
| 02/11/2009 | CN101362731A Heterocyclic compounds and methods of use |
| 02/11/2009 | CN101361983A Lung cancer DNA plasmid vaccine and preparation method thereof |
| 02/11/2009 | CN101361956A Traditional Chinese medicine cataplasm for treating measles complicated pneumonia |
| 02/11/2009 | CN101361952A Traditional Chinese medicine preparation for treating cold |
| 02/11/2009 | CN101361915A Plaster for treating pneumonia |
| 02/11/2009 | CN101361904A Traditional Chinese medicine prescription for treating allergic rhinitis |
| 02/11/2009 | CN101361895A Traditional Chinese medicine combination for treating measles complicated pneumonia |
| 02/11/2009 | CN101361869A Quality control method of tables for treating asthma |
| 02/11/2009 | CN101361861A Prescription for treating chronic bronchitis |
| 02/11/2009 | CN101361857A Nasal cavity surface preparation |
| 02/11/2009 | CN101361846A Detoxification fever-reduction traditional Chinese medicine for treating internal medical excess fire disease and production method thereof |
| 02/11/2009 | CN101361845A Traditional Chinese medicine for treating chest tightness |
| 02/11/2009 | CN101361820A Traditional Chinese medicine combination for clearing away the heat-evil and expelling superficial evils, bacterial resisting and diminishing inflammation, preventing asthma and relieving cough and pr |